Natural history and nonoperative management of penetrating cerebrovascular injury

Injury. 2023 Jan;54(1):131-137. doi: 10.1016/j.injury.2022.10.030. Epub 2022 Nov 2.

Abstract

Introduction: There is a modern precedent for nonoperative management of select penetrating cerebrovascular injuries (PCVIs); however, there is minimal data to guide management.

Patients and methods: This study assessed treatments, radiographic injury progression, and outcomes for all patients with PCVIs managed at an urban Level I trauma center from 2016 to 2021 that underwent initial nonoperative management (NOM).

Results: Fourteen patients were included. There were 11,635 trauma admissions, 378 patients with blunt cerebrovascular injury, and 18 patients with operatively-managed PCVI during this timeframe. All patients received antithrombotic therapy, but this was delayed in some due to concomitant injuries. Three patients had stroke (21%): two before antithrombotic initiation, and one with unclear timing relative to treatment. Three patients underwent endovascular interventions. On follow-up imaging, 14% had injury resolution, 36% were stable, 21% worsened, and 29% had no follow-up vascular imaging. One patient died (7%), one had a bleeding complication (7%), and no patient required delayed operative intervention.

Discussion: Early initiation of antithrombotic therapy, early surveillance imaging, and selective use of endovascular interventions are important for nonoperative management of PCVI.

Keywords: Nonoperative management; Penetrating cerebrovascular injury; Stroke, antithrombotic therapy.

MeSH terms

  • Cerebrovascular Trauma* / complications
  • Cerebrovascular Trauma* / diagnostic imaging
  • Cerebrovascular Trauma* / therapy
  • Diagnostic Imaging
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Injury Severity Score
  • Retrospective Studies
  • Treatment Outcome
  • Wounds, Nonpenetrating* / therapy
  • Wounds, Penetrating* / surgery

Substances

  • Fibrinolytic Agents